COLUMBIA, Md.--(BUSINESS WIRE)--Heartscape Technologies today announced the election of Barry W. Wilson by the Heartscape Board to serve as Independent Director and Chairman of the Board. Wilson joins Heartscape following his recent retirement as Senior Vice President of Medtronic, Inc. and President, Medtronic International. He was also a member of the Medtronic Executive Committee reporting to the CEO and was President of Medtronic Greater China. Wilson held several prior executive positions in the pharmaceutical industry, including President of Bristol-Myers Squibb Intercontinental, and President, International, of the Lederle Laboratories Division of American Cyanamid Company. He has also served as a member of the Board of Directors of Bausch and Lomb and of Mallinkrodt, Inc. until their acquisition and merger, respectively, and was recently appointed to the Board of Directors of Welch-Allyn. Since his retirement from Medtronic, Wilson has accepted several distinguished Board and advisory roles in addition to his role at Heartscape. “We are truly fortunate to have Barry on the Heartscape team. All of us look forward to working with him to learn from his experience and to benefit from his broad network of business and personal relationships,” said Arthur Hiller, Chief Executive Officer of Heartscape.
